AXSOME THERAPEUTICS, INC. Accrued Royalties, Current
AXSOME THERAPEUTICS, INC. (AXSM) had Accrued Royalties, Current of $8.46 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-10
- 2026-06-30: Accrued Royalties, Current $8.46M.
- 2026-03-31: Accrued Royalties, Current $12.25M.
- 2025-12-31: Accrued Royalties, Current $7.90M.
- 2025-09-30: Accrued Royalties, Current $7.00M.
| Period end | Accrued Royalties, Current | Accrued Royalties, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.46M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $12.25M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $7.90M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $7.00M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $6.08M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $7.91M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $9.96M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $4.54M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $5.43M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $3.50M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $5.93M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $9.24M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $8.13M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $6.46M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.62M 10-K · filed 2024-02-23 | $1.62M 10-K · filed 2023-02-28 |
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $705.58K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |